Dascena
Oakland, California, 94612, United States
NCT Number: NCT04390516
The purpose of this study is to prospectively evaluate a machine learning algorithm for the prediction of outcomes in COVID-19 patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oakland, California, 94612, United States
In a multi-center prospective clinical trial, a machine learning algorithm was deployed at five partner hospitals to analyze live patient data, including blood pressure and Creatinine levels, to determine the algorithm's ability to predict COVID-19 patient prognosis. The primary endpoint was mechanical ventilation of study subjects within 24 hours after hospital admission separate from a decompensation alert related to oxygen levels.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The COViage machine learning algorithm is designed to predict mechanical ventilation and mortality within 24 hours after hospital admission.
Time frame: Through study completion, an average of 2 months
Ventilated or not ventilated within 24 hours
Time frame: Through study completion, an average of 2 months
Death or ventilated, or no death or not ventilated within 24 hours
Dascena
Industry
Prediction Of Respiratory Decompensation In Covid-19 Patients Using Machine Learning: The READY Trial
Acronym: READY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04423991
COVID-19, Coronaviridae Infections
Oakland, California, United States
View Trial DetailsNCT04341792
COVID-19, Coronaviridae Infections
Lille, France
View Trial DetailsNCT04331886
COVID-19, Coronaviridae Infections
Seattle, Washington, United States
View Trial DetailsNCT04335084
COVID, COVID-19
Ventura, California, United States
View Trial Details